Abstract
Almost 10% of the world’s population is affected by alcohol use disorder (AUD). The combination between psychosocial intervention and pharmacological treatment seems to be the most effective approach for patients affected by AUD. Among effective drugs useful in the treatment of AUD, GABAB-ergic medications have been tested with encouraging results (i.e. sodium oxybate, baclofen, gabapentin, pregabalin and tiagabine). The present review will summarize available data on these medications.
| Original language | English |
|---|---|
| Pages (from-to) | 3367-3372 |
| Number of pages | 6 |
| Journal | Current Pharmaceutical Design |
| Volume | 21 |
| Issue number | 23 |
| Publication status | Published - Jul 1 2015 |
Fingerprint
Keywords
- Alcohol use disorder
- Craving
- GABA<inf>B</inf> agonists
- Pharmacological treatment
ASJC Scopus subject areas
- Drug Discovery
- Pharmacology
Cite this
Mirijello, A., Caputo, F., Vassallo, G., Rolland, B., Tarli, C., Gasbarrini, A., & Addolorato, G. (2015). GabaB agonists for the treatment of alcohol use disorder. Current Pharmaceutical Design, 21(23), 3367-3372.